GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » EV-to-EBITDA

Amniotics AB (OSTO:AMNI) EV-to-EBITDA : -0.24 (As of May. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Amniotics AB's enterprise value is kr4.83 Mil. Amniotics AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was kr-20.45 Mil. Therefore, Amniotics AB's EV-to-EBITDA for today is -0.24.

The historical rank and industry rank for Amniotics AB's EV-to-EBITDA or its related term are showing as below:

OSTO:AMNI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -22.56   Med: 0   Max: 0.38
Current: -0.24

During the past 4 years, the highest EV-to-EBITDA of Amniotics AB was 0.38. The lowest was -22.56. And the median was 0.00.

OSTO:AMNI's EV-to-EBITDA is ranked worse than
100% of 456 companies
in the Biotechnology industry
Industry Median: 10.52 vs OSTO:AMNI: -0.24

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Amniotics AB's stock price is kr0.0039. Amniotics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was kr-0.198. Therefore, Amniotics AB's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Amniotics AB EV-to-EBITDA Historical Data

The historical data trend for Amniotics AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB EV-to-EBITDA Chart

Amniotics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
- - -2.55 -0.56

Amniotics AB Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.90 -0.67 -0.56 -0.29 -0.28

Competitive Comparison of Amniotics AB's EV-to-EBITDA

For the Biotechnology subindustry, Amniotics AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amniotics AB's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Amniotics AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Amniotics AB's EV-to-EBITDA falls into.



Amniotics AB EV-to-EBITDA Calculation

Amniotics AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4.828/-20.446
=-0.24

Amniotics AB's current Enterprise Value is kr4.83 Mil.
Amniotics AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-20.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amniotics AB  (OSTO:AMNI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Amniotics AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0039/-0.198
=At Loss

Amniotics AB's share price for today is kr0.0039.
Amniotics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.198.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Amniotics AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Amniotics AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Amniotics AB (OSTO:AMNI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Lund, SWE, 223 63
Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.

Amniotics AB (OSTO:AMNI) Headlines

From GuruFocus